ORIC vs ZYME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

ORIC

54.3
AI Score
VS
ORIC Wins

ZYME

49.1
AI Score

Investment Advisor Scores

ORIC

54score
Recommendation
HOLD

ZYME

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ORIC ZYME Winner
Forward P/E 0 22.0264 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% -91.1% ORIC
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 54.3/100 49.1/100 ORIC
Profit Margin 0.0% -126.3% ORIC
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ORIC 1M: -8.5% · 3M: +9.0% ZYME 1M: -16.8% · 3M: -17.7%

Current Technical Phase

ORIC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.0 · Price: $10.65

ZYME

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.2%), weak momentum, RSI 35

RSI (14): 34.9 · Price: $21.89

Fundamentals Snapshot

Metric ORIC ZYME
Market Cap
Forward P/E -6.9 42.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.9%
Gross Margin -0.7%
Operating Margin 0.0% -19.6%
EPS -1.44 -1.37
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ORIC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.